Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person 15-lipoxygenase (ALOX15) can mediate a second lipoxygenation...
| Class:Id | Summation:9024878 |
|---|---|
| _displayName | 15-lipoxygenase (ALOX15) can mediate a second lipoxygenation... |
| _timestamp | 2017-11-10 16:21:32 |
| created | [InstanceEdit:9024874] Jassal, Bijay, 2017-10-10 |
| modified | [InstanceEdit:9028817] Jassal, Bijay, 2017-11-10 |
| text | 15-lipoxygenase (ALOX15) can mediate a second lipoxygenation reaction where 17(S)-Hp-DHA is oxidised to the production of the protectin D1 (PD1) isomer PDX (Hong et al. 2003, Serhan et al. 2006, Chen et al. 2009). The chemical structure of PDX is 10(S),17(S)-dihydroxy-docosahexa-4Z,7Z,11E,13Z,15E,19Z-enoic acid. It differs from PD1, having E,Z,E geometry (PDX) instead of E,E,Z (PD1) and S configuration at carbon 10 instead of R (Chen et al. 2009). PDX is not a major product of leukocytes and has low potency compared to PD1 as a regulator of polymorphonuclear leukocyte (PMN) infiltration (Serhan et al. 2006). |
| (summation) | [Reaction:9024872] ALOX15 oxidises 17(S)-Hp-DHA to PDX [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by 15-lipoxygenase (ALOX15) can mediate a second lipoxygenation... (9024878)
